Immunization, HepB3 in Poland
Poland: Immunization, HepB3 was 87.0% in 2024. ▲ Rising
Immunization, HepB3 in Poland, 1991–2024
Source: World Health Organization (WHO). Measured in % of one-year-old children.
Analysis
In 2024, immunization, hepb3 in Poland stood at 87.0%.
That represents a change of down 3.3% on the previous year and down 9.4% over ten years.
Over the whole period, immunization, hepb3 in Poland peaked at 99.0% in 1998 and was at its lowest, 1.0%, in 1991.
Poland ranks 113th of 188 countries on this measure, in the middle of the range.
The long-run direction has been consistently rising across the 34 years of available data.
Immunization, HepB3 in Poland, year by year
| Year | % of one-year-old children | Change |
|---|---|---|
| 1991 | 1.0% | — |
| 1992 | 1.0% | +0.0% |
| 1993 | 1.0% | +0.0% |
| 1994 | 4.0% | +300.0% |
| 1995 | 23.0% | +475.0% |
| 1996 | 56.0% | +143.5% |
| 1997 | 97.0% | +73.2% |
| 1998 | 99.0% | +2.1% |
| 1999 | 99.0% | +0.0% |
| 2000 | 99.0% | +0.0% |
| 2001 | 95.0% | -4.0% |
| 2002 | 98.0% | +3.2% |
| 2003 | 97.0% | -1.0% |
| 2004 | 98.0% | +1.0% |
| 2005 | 98.0% | +0.0% |
| 2006 | 98.0% | +0.0% |
| 2007 | 98.0% | +0.0% |
| 2008 | 98.0% | +0.0% |
| 2009 | 98.0% | +0.0% |
| 2010 | 98.0% | +0.0% |
| 2011 | 98.0% | +0.0% |
| 2012 | 97.0% | -1.0% |
| 2013 | 96.0% | -1.0% |
| 2014 | 96.0% | +0.0% |
| 2015 | 96.0% | +0.0% |
| 2016 | 95.0% | -1.0% |
| 2017 | 93.0% | -2.1% |
| 2018 | 91.0% | -2.2% |
| 2019 | 91.0% | +0.0% |
| 2020 | 90.0% | -1.1% |
| 2021 | 89.0% | -1.1% |
| 2022 | 90.0% | +1.1% |
| 2023 | 90.0% | +0.0% |
| 2024 | 87.0% | -3.3% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 1990s | 42.3% | 1.0% | 99.0% | 9 |
| 2000s | 97.7% | 95.0% | 99.0% | 10 |
| 2010s | 95.1% | 91.0% | 98.0% | 10 |
| 2020s | 89.2% | 87.0% | 90.0% | 5 |
Countries ranked near Poland
- 113 Lithuania 87.0% compare
- 113 Pakistan 87.0% compare
- 113 Sao Tome and Principe 87.0% compare
- 113 Solomon Islands 87.0% compare
More health data for Poland
- Un projection of annual infant deaths, annual growth rate -1.23 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.9071 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,693 deaths per 1,000 people (2090)
- Number of infants who die before age 1 80 deaths (2100)
- Population ages 75-79, female, annual growth rate 10.25 % change on previous year (2025)
- Population ages 75-79, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 75-79, female, per capita 0.0244 units per person (2025)
- Population ages 75-79, male, annual growth rate 10.76 % change on previous year (2025)
- Population ages 75-79, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 75-79, male, per capita 0.016 units per person (2025)
Frequently asked questions
- What is immunization, hepb3 in Poland?
- Immunization, hepb3 in Poland was 87.0% in 2024, according to World Health Organization (WHO).
- What is the highest immunization, hepb3 recorded in Poland?
- The highest recorded value was 99.0% in 1998.
- What is the lowest immunization, hepb3 recorded in Poland?
- The lowest recorded value was 1.0% in 1991.
- How does Poland rank for immunization, hepb3?
- Poland ranks 113th out of 188 countries with data for 2024.
- Is immunization, hepb3 rising or falling in Poland?
- Over the last ten years it is down 9.4%. The long-run trend across the full record is rising.
- Where does this Poland data come from?
- The figures come from World Health Organization (WHO), published as part of Immunization, HepB3 (% of one-year-old children). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 34 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Child immunization rate, hepatitis B is the percentage of children ages 12-23 months who received hepatitis B vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized after three doses.